Earlier research has indicated that other adipokines, including adiponectin, can serve as biomarkers for metabolic processes in prediabetes, T2DM and obesity [29,30,31,32]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.